Designed to meet the evolving needs of the biopharmaceutical industry, LineaDNA enables the precise, and scalable production of high-purity linear DNA with unparalleled speed and quality control, supporting the development of safe, effective, and next-generation genetic medicines. All this within our GMP-complaint, ISO 9001/13485-based facility.
Our enzyme-driven manufacturing process offers unmatched purity and control, eliminating common contaminants such as endotoxins, plasmid backbone sequences, and unwanted genomic elements. From early discovery through clinical development, LineaDNA provides a flexible and high-performance alternative to plasmid DNA, accelerating time to results while enhancing safety and regulatory confidence.
With a focus on quality, speed, and reliability, LineaRx is your trusted partner in next-generation therapeutic innovation. Our DNA is designed to scale with your success.
LineaRx pioneers advanced DNA-based technologies for mRNA production, DNA vaccines and gene editing. Our proprietary enzymatic DNA production process delivers safer, more precise, and scalable non-viral solutions, enabling breakthroughs in personalized therapies. Committed to innovation, we empower the future of medicine.
